ArticleBlood advances2019

Role of CYP3A4 in bone marrow microenvironment-mediated protection of FLT3/ITD AML from tyrosine kinase inhibitors.

Yu-Ting Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.